Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Jihye Park; Jae Hee Cheon

doi:10.5217/ir.2017.15.3.263

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Jihye Park, Jae Hee Cheon

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	263-265
Number of pages	3
Journal	Intestinal Research
Volume	15
Issue number	3
DOIs	https://doi.org/10.5217/ir.2017.15.3.263
Publication status	Published - 2017

All Science Journal Classification (ASJC) codes

Gastroenterology

Access to Document

10.5217/ir.2017.15.3.263

Cite this

@article{6ff5ef75dbac45a8b1456f3022535038,

title = "Could adalimumab be used safely and effectively in intestinal Beh{\c c}et's disease refractory to conventional therapy?",

author = "Jihye Park and Cheon, {Jae Hee}",

year = "2017",

doi = "10.5217/ir.2017.15.3.263",

language = "English",

volume = "15",

pages = "263--265",

journal = "Intestinal Research",

issn = "1598-9100",